TreeWAS – Variant ID: rs12370990

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
I84.6 Residual haemorrhoidal skin tags	0.000	0.959	0.041
T42.4 Benzodiazepines	0.024	0.976	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.019	0.981	0.000
T42.0 Hydantoin derivatives	0.017	0.983	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.017	0.983	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.017	0.983	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.014	0.986	0.000
T42.3 Barbiturates	0.014	0.986	0.000
T42.2 Succinimides and oxazolidinediones	0.014	0.986	0.000
T42.1 Iminostilbenes	0.014	0.986	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.012	0.988	0.000
S82.10 Fracture of upper end of tibia (closed)	0.009	0.991	0.000
K41.9 Unilateral or unspecified femoral hernia, without obstruction or gangrene	0.000	0.991	0.009
K11.5 Sialolithiasis	0.000	0.993	0.007
K11.2 Sialoadenitis	0.000	0.993	0.007
K11 Diseases of salivary glands	0.000	0.993	0.007
K11.8 Other diseases of salivary glands	0.000	0.993	0.007
D32.0 Cerebral meninges	0.007	0.993	0.000
K11.3 Abscess of salivary gland	0.000	0.993	0.007
J93.9 Pneumothorax, unspecified	0.007	0.993	0.000
E88.0 Disorders of plasma-protein metabolism, not elsewhere classified	0.006	0.994	0.000
L60.0 Ingrowing nail	0.000	0.994	0.006
K41 Femoral hernia	0.000	0.994	0.006
K11.4 Fistula of salivary gland	0.000	0.995	0.005
K11.0 Atrophy of salivary gland	0.000	0.995	0.005
K11.7 Disturbances of salivary secretion	0.000	0.995	0.005
K41.3 Unilateral or unspecified femoral hernia, with obstruction, without gangrene	0.000	0.995	0.005
K11.6 Mucocele of salivary gland	0.000	0.995	0.005
J93.8 Other pneumothorax	0.005	0.995	0.000
J93 Pneumothorax	0.005	0.995	0.000
G04.9 Encephalitis, myelitis and encephalomyelitis, unspecified	0.005	0.995	0.000
L60 Nail disorders	0.000	0.995	0.005
K62.3 Rectal prolapse	0.000	0.995	0.005
Z11.2 Special screening examination for other bacterial diseases	0.005	0.995	0.000
Q38.7 Pharyngeal pouch	0.005	0.995	0.000
K11.9 Disease of salivary gland, unspecified	0.000	0.995	0.004
L60.9 Nail disorder, unspecified	0.000	0.996	0.004
K11.1 Hypertrophy of salivary gland	0.000	0.996	0.004
K41.4 Unilateral or unspecified femoral hernia, with gangrene	0.000	0.996	0.004
K41.2 Bilateral femoral hernia, without obstruction or gangrene	0.000	0.996	0.004
K41.1 Bilateral femoral hernia, with gangrene	0.000	0.996	0.004
K41.0 Bilateral femoral hernia, with obstruction, without gangrene	0.000	0.996	0.004
L60.2 Onychogryphosis	0.000	0.996	0.004
J93.0 Spontaneous tension pneumothorax	0.004	0.996	0.000
S82.1 Fracture of upper end of tibia	0.004	0.996	0.000
G62.8 Other specified polyneuropathies	0.004	0.996	0.000
G63.2 Diabetic polyneuropathy	0.000	0.996	0.004
E88 Other metabolic disorders	0.004	0.996	0.000
L60.3 Nail dystrophy	0.000	0.996	0.004
C45.0 Mesothelioma of pleura	0.004	0.996	0.000
M65.34 Trigger finger-Hand	0.004	0.996	0.000
J93.1 Other spontaneous pneumothorax	0.004	0.996	0.000
L60.5 Yellow nail syndrome	0.000	0.996	0.003
L60.4 Beau's lines	0.000	0.996	0.003
T36-T50 Poisoning by drugs, medicaments and biological substances	0.004	0.996	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.003	0.996	0.000
Q38 Other congenital malformations of tongue, mouth and pharynx	0.003	0.997	0.000
E88.9 Metabolic disorder, unspecified	0.003	0.997	0.000
E88.8 Other specified metabolic disorders	0.003	0.997	0.000
N18.2 Chronic kidney disease, stage 2	0.000	0.997	0.003
E88.1 Lipodystrophy, not elsewhere classified	0.003	0.997	0.000
L60.8 Other nail disorders	0.000	0.997	0.003
L60.1 Onycholysis	0.000	0.997	0.003
S82.11 Fracture of upper end of tibia (open)	0.003	0.997	0.000
E85.9 Amyloidosis, unspecified	0.003	0.997	0.000
K62.0 Anal polyp	0.000	0.997	0.003
C45 Mesothelioma	0.003	0.997	0.000
C45.7 Mesothelioma of other sites	0.003	0.997	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.003	0.997	0.000
E24.9 Cushing's syndrome, unspecified	0.003	0.997	0.000
T36 Poisoning by systemic antibiotics	0.003	0.997	0.000
T47.0 Histamine H(2)-receptor antagonists	0.003	0.997	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.003	0.997	0.000
E11.5 With peripheral circulatory complications	0.000	0.997	0.003
E88.2 Lipomatosis, not elsewhere classified	0.003	0.997	0.000
T47.2 Stimulant laxatives	0.003	0.997	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.003	0.997	0.000
E88.3 Tumour lysis syndrome	0.003	0.997	0.000
C09.9 Tonsil, unspecified	0.003	0.997	0.000
C45.9 Mesothelioma, unspecified	0.003	0.997	0.000
T36.0 Penicillins	0.003	0.997	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.003	0.997	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.003	0.997	0.000
J32.0 Chronic maxillary sinusitis	0.003	0.997	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.003	0.997	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.003	0.997	0.000
T47.7 Emetics	0.003	0.997	0.000
T47.6 Antidiarrhoeal drugs	0.003	0.997	0.000
T47.5 Digestants	0.003	0.997	0.000
T47.4 Other laxatives	0.003	0.997	0.000
T47.3 Saline and osmotic laxatives	0.003	0.997	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.003	0.997	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.003	0.997	0.000
Q44 Congenital malformations of gallbladder, bile ducts and liver	0.003	0.997	0.000
Q38.8 Other congenital malformations of pharynx	0.003	0.997	0.000
Q38.6 Other congenital malformations of mouth	0.003	0.997	0.000
Q38.5 Congenital malformations of palate, not elsewhere classified	0.003	0.997	0.000
Q38.4 Congenital malformations of salivary glands and ducts	0.003	0.997	0.000
Q38.3 Other congenital malformations of tongue	0.003	0.997	0.000
Q38.2 Macroglossia	0.003	0.997	0.000
Q38.0 Congenital malformations of lips, not elsewhere classified	0.003	0.997	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.003	0.997	0.000
Q44.5 Other congenital malformations of bile ducts	0.003	0.997	0.000
E73.9 Lactose intolerance, unspecified	0.003	0.997	0.000
Q38.1 Ankyloglossia	0.002	0.997	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.003	0.997	0.000
Q38-Q45 Other congenital malformations of the digestive system	0.003	0.997	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.002	0.997	0.000
L90.0 Lichen sclerosus et atrophicus	0.000	0.997	0.003
Q44.6 Cystic disease of liver	0.003	0.997	0.000
C45.2 Mesothelioma of pericardium	0.002	0.997	0.000
C45.1 Mesothelioma of peritoneum	0.002	0.997	0.000
E61.1 Iron deficiency	0.000	0.997	0.003
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.002	0.997	0.000
T36.9 Systemic antibiotic, unspecified	0.002	0.997	0.000
T36.8 Other systemic antibiotics	0.002	0.997	0.000
T36.7 Antifungal antibiotics, systemically used	0.002	0.997	0.000
T36.6 Rifamycins	0.002	0.997	0.000
T36.5 Aminoglycosides	0.002	0.997	0.000
T36.4 Tetracyclines	0.002	0.997	0.000
T36.3 Macrolides	0.002	0.997	0.000
T36.2 Chloramphenicol group	0.002	0.997	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.002	0.997	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.002	0.997	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.002	0.997	0.000
E85 Amyloidosis	0.002	0.997	0.000
Q40 Other congenital malformations of upper alimentary tract	0.002	0.998	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.002	0.998	0.000
T37.5 Antiviral drugs	0.002	0.998	0.000
T37.4 Anthelminthics	0.002	0.998	0.000
T37.3 Other antiprotozoal drugs	0.002	0.998	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.002	0.998	0.000
T37.1 Antimycobacterial drugs	0.002	0.998	0.000
T37.0 Sulphonamides	0.002	0.998	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.002	0.998	0.000
E85.4 Organ-limited amyloidosis	0.002	0.998	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.002	0.998	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.002	0.998	0.000
Q43 Other congenital malformations of intestine	0.002	0.998	0.000
T49.9 Topical agent, unspecified	0.002	0.998	0.000
T49.8 Other topical agents	0.002	0.998	0.000
T49.7 Dental drugs, topically applied	0.002	0.998	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.002	0.998	0.000
T49.5 Ophthalmological drugs and preparations	0.002	0.998	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.002	0.998	0.000
T49.3 Emollients, demulcents and protectants	0.002	0.998	0.000
T49.2 Local astringents and local detergents	0.002	0.998	0.000
T49.1 Antipruritics	0.002	0.998	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.002	0.998	0.000
G93.9 Disorder of brain, unspecified	0.002	0.998	0.000
T41.5 Therapeutic gases	0.002	0.998	0.000
T41.4 Anaesthetic, unspecified	0.002	0.998	0.000
T41.3 Local anaesthetics	0.002	0.998	0.000
T41.2 Other and unspecified general anaesthetics	0.002	0.998	0.000
T41.1 Intravenous anaesthetics	0.002	0.998	0.000
T41.0 Inhaled anaesthetics	0.002	0.998	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.002	0.998	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.002	0.998	0.000
T48.5 Anti-common-cold drugs	0.002	0.998	0.000
T48.4 Expectorants	0.002	0.998	0.000
T48.3 Antitussives	0.002	0.998	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.002	0.998	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.002	0.998	0.000
T48.0 Oxytocic drugs	0.002	0.998	0.000
M54.57 Low back pain (Lumbosacral region)	0.000	0.998	0.002
Q40.3 Congenital malformation of stomach, unspecified	0.002	0.998	0.000
Q44.7 Other congenital malformations of liver	0.002	0.998	0.000
Q44.4 Choledochal cyst	0.002	0.998	0.000
Q44.3 Congenital stenosis and stricture of bile ducts	0.002	0.998	0.000
Q44.2 Atresia of bile ducts	0.002	0.998	0.000
Q44.1 Other congenital malformations of gallbladder	0.002	0.998	0.000
Q44.0 Agenesis, aplasia and hypoplasia of gallbladder	0.002	0.998	0.000
S30.9 Superficial injury of abdomen, lower back and pelvis, part unspecified	0.002	0.998	0.000
Z36.3 Antenatal screening for malformations using ultrasound and other physical methods	0.002	0.998	0.000
Q40.2 Other specified congenital malformations of stomach	0.002	0.998	0.000
Q43.3 Congenital malformations of intestinal fixation	0.002	0.998	0.000
T43.9 Psychotropic drug, unspecified	0.002	0.998	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.002	0.998	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.002	0.998	0.000
Q42 Congenital absence, atresia and stenosis of large intestine	0.002	0.998	0.000
Q41 Congenital absence, atresia and stenosis of small intestine	0.002	0.998	0.000
O46.9 Antepartum haemorrhage, unspecified	0.000	0.998	0.002
T38.1 Thyroid hormones and substitutes	0.002	0.998	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.002	0.998	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.002	0.998	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.002	0.998	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.002	0.998	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.002	0.998	0.000
T44.0 Anticholinesterase agents	0.002	0.998	0.000
T50.8 Diagnostic agents	0.002	0.998	0.000
Q43.9 Congenital malformation of intestine, unspecified	0.002	0.998	0.000
Q66.8 Other congenital deformities of feet	0.000	0.998	0.002
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.002	0.998	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.002	0.998	0.000
T50.7 Analeptics and opioid receptor antagonists	0.002	0.998	0.000
T50.5 Appetite depressants	0.002	0.998	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.002	0.998	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.002	0.998	0.000
T50.1 Loop [high-ceiling] diuretics	0.002	0.998	0.000
T50.0 Mineralocorticoids and their antagonists	0.002	0.998	0.000
T38.9 Other and unspecified hormone antagonists	0.002	0.998	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.002	0.998	0.000
T38.7 Androgens and anabolic congeners	0.002	0.998	0.000
T38.5 Other oestrogens and progestogens	0.002	0.998	0.000
T38.4 Oral contraceptives	0.002	0.998	0.000
T38.2 Antithyroid drugs	0.002	0.998	0.000
T38.0 Glucocorticoids and synthetic analogues	0.002	0.998	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.002	0.998	0.000
E85.2 Heredofamilial amyloidosis, unspecified	0.002	0.998	0.000
E85.1 Neuropathic heredofamilial amyloidosis	0.002	0.998	0.000
E85.0 Nonneuropathic heredofamilial amyloidosis	0.002	0.998	0.000
R01.0 Benign and innocent cardiac murmurs	0.000	0.998	0.002
T50.6 Antidotes and chelating agents, not elsewhere classified	0.002	0.998	0.000
Q40.9 Congenital malformation of upper alimentary tract, unspecified	0.002	0.998	0.000
Q40.8 Other specified congenital malformations of upper alimentary tract	0.002	0.998	0.000
Q40.1 Congenital hiatus hernia	0.002	0.998	0.000
Q40.0 Congenital hypertrophic pyloric stenosis	0.002	0.998	0.000
E85.8 Other amyloidosis	0.002	0.998	0.000
M45.X2 Ankylosing spondylitis (Cervical region)	0.000	0.998	0.002
T39.4 Antirheumatics, not elsewhere classified	0.002	0.998	0.000
T39.2 Pyrazolone derivatives	0.002	0.998	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.002	0.998	0.000
M86.97 Osteomyelitis, unspecified (Ankle and foot)	0.000	0.998	0.002
R86.7 Abnormal histological findings	0.002	0.998	0.000
G63 Polyneuropathy in diseases classified elsewhere	0.000	0.998	0.002
Q45 Other congenital malformations of digestive system	0.002	0.998	0.000
R85.7 Abnormal histological findings	0.002	0.998	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.002	0.998	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.002	0.998	0.000
T46.7 Peripheral vasodilators	0.002	0.998	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.002	0.998	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.002	0.998	0.000
E73 Lactose intolerance	0.002	0.998	0.000
Q43.7 Persistent cloaca	0.002	0.998	0.000
Q43.6 Congenital fistula of rectum and anus	0.002	0.998	0.000
Q43.5 Ectopic anus	0.002	0.998	0.000
Q43.4 Duplication of intestine	0.002	0.998	0.000
Q43.2 Other congenital functional disorders of colon	0.002	0.998	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.002	0.998	0.000
D32 Benign neoplasm of meninges	0.002	0.998	0.000
E85.3 Secondary systemic amyloidosis	0.002	0.998	0.000
M45.X9 Ankylosing spondylitis (Site unspecified)	0.000	0.998	0.002
T50.9 Other and unspecified drugs, medicaments and biological substances	0.002	0.998	0.000
R85.5 Abnormal microbiological findings	0.002	0.998	0.000
Q43.1 Hirschsprung's disease	0.002	0.998	0.000
I70.20 Atherosclerosis of arteries of extremities (without gangrene)	0.000	0.998	0.002
Q43.0 Meckel's diverticulum	0.002	0.998	0.000
R89.7 Abnormal histological findings	0.002	0.998	0.000
G04 Encephalitis, myelitis and encephalomyelitis	0.002	0.998	0.000
T46.1 Calcium-channel blockers	0.002	0.998	0.000
C09 Malignant neoplasm of tonsil	0.002	0.998	0.000
Q39 Congenital malformations of oesophagus	0.002	0.998	0.000
K35.0 Acute appendicitis with generalised peritonitis	0.002	0.998	0.000
Q41.9 Congenital absence, atresia and stenosis of small intestine, part unspecified	0.002	0.998	0.000
Q41.8 Congenital absence, atresia and stenosis of other specified parts of small intestine	0.002	0.998	0.000
Q41.2 Congenital absence, atresia and stenosis of ileum	0.002	0.998	0.000
Q41.1 Congenital absence, atresia and stenosis of jejunum	0.002	0.998	0.000
Q41.0 Congenital absence, atresia and stenosis of duodenum	0.002	0.998	0.000
Q42.9 Congenital absence, atresia and stenosis of large intestine, part unspecified	0.002	0.998	0.000
Q42.8 Congenital absence, atresia and stenosis of other parts of large intestine	0.002	0.998	0.000
Q42.3 Congenital absence, atresia and stenosis of anus without fistula	0.002	0.998	0.000
Q42.2 Congenital absence, atresia and stenosis of anus with fistula	0.002	0.998	0.000
Q42.1 Congenital absence, atresia and stenosis of rectum without fistula	0.002	0.998	0.000
Q42.0 Congenital absence, atresia and stenosis of rectum with fistula	0.002	0.998	0.000
T43.6 Psychostimulants with abuse potential	0.002	0.998	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.002	0.998	0.000
R85 Abnormal findings in specimens from digestive organs and abdominal cavity	0.002	0.998	0.000
Q18.1 Preauricular sinus and cyst	0.000	0.998	0.002
Q18.0 Sinus, fistula and cyst of branchial cleft	0.000	0.998	0.002
T50.4 Drugs affecting uric acid metabolism	0.002	0.998	0.000
T90.4 Sequelae of injury of eye and orbit	0.000	0.998	0.002
M65.3 Trigger finger	0.002	0.998	0.000
Q43.8 Other specified congenital malformations of intestine	0.002	0.998	0.000
E27.4 Other and unspecified adrenocortical insufficiency	0.000	0.998	0.002
T43.0 Tricyclic and tetracyclic antidepressants	0.002	0.998	0.000
E24 Cushing's syndrome	0.001	0.998	0.000
C09.0 Tonsillar fossa	0.002	0.998	0.000
E27.1 Primary adrenocortical insufficiency	0.000	0.998	0.002
F23.9 Acute and transient psychotic disorder, unspecified	0.000	0.998	0.002
G63.8 Polyneuropathy in other diseases classified elsewhere	0.000	0.998	0.001
G63.6 Polyneuropathy in other musculoskeletal disorders	0.000	0.998	0.001
G63.5 Polyneuropathy in systemic connective tissue disorders	0.000	0.998	0.001
G63.4 Polyneuropathy in nutritional deficiency	0.000	0.998	0.001
G63.3 Polyneuropathy in other endocrine and metabolic diseases	0.000	0.998	0.001
G63.1 Polyneuropathy in neoplastic disease	0.000	0.998	0.001
G63.0 Polyneuropathy in infectious and parasitic diseases classified elsewhere	0.000	0.998	0.001
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.002	0.998	0.000
C48.2 Peritoneum, unspecified	0.002	0.998	0.000
E73.8 Other lactose intolerance	0.002	0.998	0.000
E73.1 Secondary lactase deficiency	0.002	0.998	0.000
E73.0 Congenital lactase deficiency	0.002	0.998	0.000
N81.5 Vaginal enterocele	0.000	0.998	0.002
Q45.9 Congenital malformation of digestive system, unspecified	0.001	0.998	0.000
Q45.3 Other congenital malformations of pancreas and pancreatic duct	0.001	0.998	0.000
Q45.2 Congenital pancreatic cyst	0.001	0.998	0.000
Q45.1 Annular pancreas	0.001	0.998	0.000
Q45.0 Agenesis, aplasia and hypoplasia of pancreas	0.001	0.998	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.001	0.998	0.000
R85.9 Unspecified abnormal finding	0.002	0.998	0.000
G57.8 Other mononeuropathies of lower limb	0.002	0.998	0.000
R01.1 Cardiac murmur, unspecified	0.000	0.998	0.002
B95.2 Streptococcus, group D, as the cause of diseases classified to other chapters	0.000	0.998	0.002
C16.9 Stomach, unspecified	0.002	0.998	0.000
E05.9 Thyrotoxicosis, unspecified	0.000	0.998	0.002
E74.3 Other disorders of intestinal carbohydrate absorption	0.002	0.998	0.000
O34.1 Maternal care for tumour of corpus uteri	0.000	0.998	0.002
M45.X0 Ankylosing spondylitis (Multiple sites in spine)	0.000	0.998	0.002
M25.75 Osteophyte (Pelvic region and thigh)	0.002	0.998	0.000
M48.56 Collapsed vertebra, not elsewhere classified (Lumbar region)	0.000	0.998	0.002
G04.2 Bacterial meningoencephalitis and meningomyelitis, not elsewhere classified	0.001	0.998	0.000
G04.1 Tropical spastic paraplegia	0.001	0.998	0.000
G04.0 Acute disseminated encephalitis	0.001	0.998	0.000
M45 Ankylosing spondylitis	0.000	0.998	0.002
S42.10 Fracture of scapula (closed)	0.000	0.998	0.002
C09.8 Overlapping lesion of tonsil	0.001	0.998	0.000
C09.1 Tonsillar pillar (anterior) (posterior)	0.001	0.998	0.000
E80.6 Other disorders of bilirubin metabolism	0.002	0.998	0.000
Q39.9 Congenital malformation of oesophagus, unspecified	0.001	0.998	0.000
Q39.8 Other congenital malformations of oesophagus	0.001	0.998	0.000
Q39.5 Congenital dilatation of oesophagus	0.001	0.998	0.000
Q39.3 Congenital stenosis and stricture of oesophagus	0.001	0.998	0.000
Q39.2 Congenital tracheooesophageal fistula without atresia	0.001	0.998	0.000
Q39.1 Atresia of oesophagus with tracheooesophageal fistula	0.001	0.998	0.000
Q39.0 Atresia of oesophagus without fistula	0.001	0.998	0.000
R89 Abnormal findings in specimens from other organs, systems and tissues	0.002	0.998	0.000
R85.6 Abnormal cytological findings	0.001	0.998	0.000
R85.4 Abnormal immunological findings	0.001	0.998	0.000
R85.3 Abnormal level of substances chiefly nonmedicinal as to source	0.001	0.998	0.000
R85.2 Abnormal level of other drugs, medicaments and biological substances	0.001	0.998	0.000
R85.1 Abnormal level of hormones	0.001	0.998	0.000
R85.0 Abnormal level of enzymes	0.001	0.998	0.000
S99.9 Unspecified injury of ankle and foot	0.002	0.998	0.000
T39.0 Salicylates	0.002	0.998	0.000
R91 Abnormal findings on diagnostic imaging of lung	0.000	0.998	0.002
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.001	0.998	0.000
M65.39 Trigger finger-Site unspec	0.001	0.998	0.000
M65.38 Trigger finger-Other	0.001	0.998	0.000
M65.37 Trigger finger-Ankle/foot	0.001	0.998	0.000
M65.36 Trigger finger-Lower leg	0.001	0.998	0.000
M65.35 Trigger finger-Pelvic/thigh	0.001	0.998	0.000
M65.33 Trigger finger-Forearm	0.001	0.998	0.000
M65.32 Trigger finger-Upper arm	0.001	0.998	0.000
M65.31 Trigger finger-Shldr region	0.001	0.998	0.000
M65.30 Trigger finger-Mult sites	0.001	0.998	0.000
T14.9 Injury, unspecified	0.002	0.998	0.000
T40.3 Methadone	0.001	0.998	0.000
Z36.9 Antenatal screening, unspecified	0.002	0.998	0.000
D32.1 Spinal meninges	0.001	0.998	0.000
E24.2 Drug-induced Cushing's syndrome	0.001	0.998	0.000
R89.5 Abnormal microbiological findings	0.001	0.998	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.001	0.998	0.000
T40.1 Heroin	0.001	0.998	0.000
Q18 Other congenital malformations of face and neck	0.000	0.998	0.001
E80.1 Porphyria cutanea tarda	0.001	0.998	0.000
E87.7 Fluid overload	0.000	0.998	0.002
R85.8 Other abnormal findings	0.001	0.998	0.000
E24.8 Other Cushing's syndrome	0.001	0.998	0.000
E24.4 Alcohol-induced pseudo-Cushing's syndrome	0.001	0.998	0.000
E24.3 Ectopic ACTH syndrome	0.001	0.998	0.000
E24.1 Nelson's syndrome	0.001	0.998	0.000
E27.3 Drug-induced adrenocortical insufficiency	0.000	0.998	0.001
N89.5 Stricture and atresia of vagina	0.002	0.998	0.000
Q45.8 Other specified congenital malformations of digestive system	0.001	0.998	0.000
T14.0 Superficial injury of unspecified body region	0.002	0.998	0.000
Z50.8 Care involving use of rehabilitation procedures	0.002	0.998	0.000
E80 Disorders of porphyrin and bilirubin metabolism	0.002	0.998	0.000
E74 Other disorders of carbohydrate metabolism	0.001	0.998	0.000
M71.26 Synovial cyst of popliteal space [Baker]-Lower Leg	0.000	0.998	0.001
A40.8 Other streptococcal septicaemia	0.000	0.998	0.001
E75.2 Other sphingolipidosis	0.001	0.998	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.001	0.998	0.000
T45.8 Other primarily systemic and haematological agents	0.001	0.998	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.001	0.998	0.000
T45.6 Fibrinolysis-affecting drugs	0.001	0.998	0.000
T45.4 Iron and its compounds	0.001	0.998	0.000
T45.3 Enzymes, not elsewhere classified	0.001	0.998	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.001	0.998	0.000
W19.2 School, other institution and public administrative area	0.002	0.998	0.000
E24.0 Pituitary-dependent Cushing's disease	0.001	0.998	0.000
R61.9 Hyperhidrosis, unspecified	0.002	0.998	0.000
E75 Disorders of sphingolipid metabolism and other lipid storage disorders	0.001	0.998	0.000
C16.0 Cardia	0.001	0.999	0.000
L05.9 Pilonidal cyst without abscess	0.000	0.999	0.001
T14.1 Open wound of unspecified body region	0.001	0.999	0.000
R86 Abnormal findings in specimens from male genital organs	0.001	0.999	0.000
T14.6 Injury of tendons and muscles of unspecified body region	0.001	0.999	0.000
U51.0 Not Previously admitted to a psyciatric hospital	0.001	0.999	0.000
T14 Injury of unspecified body region	0.001	0.999	0.000
I70.21 Atherosclerosis of arteries of extremities (with gangrene)	0.000	0.999	0.001
S36.00 Injury of spleen (without open wound into cavity)	0.000	0.999	0.001
E80.2 Other porphyria	0.001	0.999	0.000
Q39.6 Diverticulum of oesophagus	0.001	0.999	0.000
Q39.4 Oesophageal web	0.001	0.999	0.000
E27 Other disorders of adrenal gland	0.000	0.999	0.001
M45.X8 Ankylosing spondylitis (Sacral and sacrococcygeal region)	0.000	0.999	0.001
M45.X7 Ankylosing spondylitis (Lumbosacral region)	0.000	0.999	0.001
M45.X5 Ankylosing spondylitis (Thoracolumbar region)	0.000	0.999	0.001
M45.X4 Ankylosing spondylitis (Thoracic region)	0.000	0.999	0.001
M45.X3 Ankylosing spondylitis (Cervicothoracic region)	0.000	0.999	0.001
M45.X1 Ankylosing spondylitis (Occipito-atlanto-axial region)	0.000	0.999	0.001
R89.9 Unspecified abnormal finding	0.001	0.999	0.000
R89.8 Other abnormal findings	0.001	0.999	0.000
R89.6 Abnormal cytological findings	0.001	0.999	0.000
R89.4 Abnormal immunological findings	0.001	0.999	0.000
R89.3 Abnormal level of substances chiefly nonmedicinal as to source	0.001	0.999	0.000
R89.2 Abnormal level of other drugs, medicaments and biological substances	0.001	0.999	0.000
R89.1 Abnormal level of hormones	0.001	0.999	0.000
R89.0 Abnormal level of enzymes	0.001	0.999	0.000
V28.9 Unspecified motorcycle rider injured in traffic accident	0.001	0.999	0.000
Z64.0 Problems related to unwanted pregnancy	0.001	0.999	0.000
E70-E90 Metabolic disorders	0.001	0.999	0.000
I69.4 Sequelae of stroke, not specified as haemorrhage or infarction	0.001	0.999	0.000
S51.8 Open wound of other parts of forearm	0.001	0.999	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.001	0.999	0.000
T40.8 Lysergide [LSD]	0.001	0.999	0.000
T40.7 Cannabis (derivatives)	0.001	0.999	0.000
T40.5 Cocaine	0.001	0.999	0.000
T40.0 Opium	0.001	0.999	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.001	0.999	0.000
R01 Cardiac murmurs and other cardiac sounds	0.000	0.999	0.001
M23.83 Other internal derangements of knee (Medial collateral ligament or Other and unspecified medial meniscus)	0.000	0.999	0.001
E75.5 Other lipid storage disorders	0.001	0.999	0.000
Q18.9 Congenital malformation of face and neck, unspecified	0.000	0.999	0.001
Q18.8 Other specified congenital malformations of face and neck	0.000	0.999	0.001
Q18.7 Microcheilia	0.000	0.999	0.001
Q18.6 Macrocheilia	0.000	0.999	0.001
Q18.5 Microstomia	0.000	0.999	0.001
Q18.4 Macrostomia	0.000	0.999	0.001
Q18.3 Webbing of neck	0.000	0.999	0.001
Q18.2 Other branchial cleft malformations	0.000	0.999	0.001
R86.9 Unspecified abnormal finding	0.001	0.999	0.000
S69.9 Unspecified injury of wrist and hand	0.001	0.999	0.000
E74.9 Disorder of carbohydrate metabolism, unspecified	0.001	0.999	0.000
E74.8 Other specified disorders of carbohydrate metabolism	0.001	0.999	0.000
E74.4 Disorders of pyruvate metabolism and gluconeogenesis	0.001	0.999	0.000
E74.2 Disorders of galactose metabolism	0.001	0.999	0.000
E74.1 Disorders of fructose metabolism	0.001	0.999	0.000
E74.0 Glycogen storage disease	0.001	0.999	0.000
E80.7 Disorder of bilirubin metabolism, unspecified	0.001	0.999	0.000
E80.5 Crigler-Najjar syndrome	0.001	0.999	0.000
E80.3 Defects of catalase and peroxydase	0.001	0.999	0.000
E80.0 Hereditary erythropoietic porphyria	0.001	0.999	0.000
Q66 Congenital deformities of feet	0.000	0.999	0.001
M54.50 Low back pain (Multiple sites in spine)	0.000	0.999	0.001
E27.9 Disorder of adrenal gland, unspecified	0.000	0.999	0.001
Q66.3 Other congenital varus deformities of feet	0.000	0.999	0.001
E61 Deficiency of other nutrient elements	0.000	0.999	0.001
D04.6 Skin of upper limb, including shoulder	0.001	0.999	0.000
E75.6 Lipid storage disorder, unspecified	0.001	0.999	0.000
E75.4 Neuronal ceroid lipofuscinosis	0.001	0.999	0.000
E75.3 Sphingolipidosis, unspecified	0.001	0.999	0.000
E75.1 Other gangliosidosis	0.001	0.999	0.000
E75.0 GM2 gangliosidosis	0.001	0.999	0.000
I70.2 Atherosclerosis of arteries of the extremities	0.000	0.999	0.001
J20.9 Acute bronchitis, unspecified	0.000	0.999	0.001
R86.5 Abnormal microbiological findings	0.001	0.999	0.000
R86.4 Abnormal immunological findings	0.001	0.999	0.000
R86.3 Abnormal level of substances chiefly nonmedicinal as to source	0.001	0.999	0.000
R86.2 Abnormal level of other drugs, medicaments and biological substances	0.001	0.999	0.000
R86.1 Abnormal level of hormones	0.001	0.999	0.000
R86.0 Abnormal level of enzymes	0.001	0.999	0.000
T43.2 Other and unspecified antidepressants	0.001	0.999	0.000
T45.2 Vitamins, not elsewhere classified	0.001	0.999	0.000
C48 Malignant neoplasm of retroperitoneum and peritoneum	0.001	0.999	0.000
E27.5 Adrenomedullary hyperfunction	0.000	0.999	0.001
E27.0 Other adrenocortical overactivity	0.000	0.999	0.001
G04.8 Other encephalitis, myelitis and encephalomyelitis	0.001	0.999	0.000
R09.0 Asphyxia	0.000	0.999	0.001
T14.2 Fracture of unspecified body region	0.001	0.999	0.000
T14.8 Other injuries of unspecified body region	0.001	0.999	0.000
T14.7 Crushing injury and traumatic amputation of unspecified body region	0.001	0.999	0.000
T14.5 Injury of blood vessel(s) of unspecified body region	0.001	0.999	0.000
T14.4 Injury of nerve(s) of unspecified body region	0.001	0.999	0.000
T14.3 Dislocation, sprain and strain of unspecified body region	0.001	0.999	0.000
Z89.4 Acquired absence of foot and ankle	0.000	0.999	0.001
E27.2 Addisonian crisis	0.000	0.999	0.001
M34.9 Systemic sclerosis, unspecified	0.000	0.999	0.001
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.001	0.999	0.000
V48.4 Person injured while boarding or alighting	0.001	0.999	0.000
X41.9 Unspecified place	0.001	0.999	0.000
E77 Disorders of glycoprotein metabolism	0.001	0.999	0.000
E76 Disorders of glycosaminoglycan metabolism	0.001	0.999	0.000
E72 Other disorders of amino-acid metabolism	0.001	0.999	0.000
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism	0.001	0.999	0.000
E90 Nutritional and metabolic disorders in diseases classified elsewhere	0.001	0.999	0.000
C45-C49 Malignant neoplasms of mesothelial and soft tissue	0.001	0.999	0.000
I63.3 Cerebral infarction due to thrombosis of cerebral arteries	0.001	0.999	0.000
L43.9 Lichen planus, unspecified	0.000	0.999	0.001
R01.2 Other cardiac sounds	0.000	0.999	0.001
E70 Disorders of aromatic amino-acid metabolism	0.001	0.999	0.000
D04.3 Skin of other and unspecified parts of face	0.001	0.999	0.000
H11.1 Conjunctival degenerations and deposits	0.000	0.999	0.001
M45.X6 Ankylosing spondylitis (Lumbar region)	0.000	0.999	0.001
O34.7 Maternal care for abnormality of vulva and perineum	0.000	0.999	0.001
Q66.7 Pes cavus	0.000	0.999	0.001
I95.9 Hypotension, unspecified	0.001	0.999	0.000
K04.5 Chronic apical periodontitis	0.000	0.999	0.001
Q66.6 Other congenital valgus deformities of feet	0.000	0.999	0.001

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations